TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,137.42−0.08%Brent$109.08−0.13%BTC$81,804.68−0.26%ETH$2,403.64−0.15%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,137.42−0.08%Brent$109.08−0.13%BTC$81,804.68−0.26%ETH$2,403.64−0.15%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Benitec Biopharma Inc · Overview · TradingHolo

Markets › United States › NAS › BNTC

B

Benitec Biopharma Inc

NAS:BNTCHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$8.38+3.27%At closeAt close · Mon 19 Oct · ≈ AED 30.76 · Market cap $292.14M · Next earnings Mon 16 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

+3.3%

1M

−28.6%

3M

−32.2%

6M

−42.4%

1Y

−49.0%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

BNTC +3.27% today

✦ This week in three lines

No written digest yet for BNTC. The figures on this page are the source when one is written.

Financials

USD millions · annual5Y CAGR —

Valuation

P/E vs sector−6.2× vs −1.7×

Price / Book vs sector1.6× vs 2.0×

Price / Sales vs sector—

Price / Free cash flow vs sector−17.0× vs −1.6×

Forecasts

7 buy0 hold0 sell7 analysts

Average target$16.00 +91.0%

Analysts1

EPS surprises, last 85 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth0

Latest news

All BNTC news →

TRBenitec Biopharma Inc. Stock 12‑Month Price Target Raised to $24.33, Implies 171% Upside

TradingView · 14 d ago

TRBenitec Biopharma says BB-301 pivotal trial on track to start mid-2027 after FDA Type C feedback

TradingView · 15 d ago

TRBenitec Biopharma Inc. (BNTC) Gets FDA Feedback; Pivotal Design Targeted for 1Q27

TradingView · 15 d ago

Key facts

At close · Mon 19 Oct

Market cap (USD)$292.14M

P/E−6.2×

Dividend yield0.0%

52-week range$8.06 – $16.76

Avg volume (20d)196,665

Shares outstanding34,882,700

Beta0.26

Short interest6.0% of float

Next earningsMon 16 Nov

Radar Score

46

Value61

Quality54

Momentum25

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Benitec Biopharma Inc. is an emerging biotechnology firm dedicated to advancing groundbreaking genetic medicines. The company specializes in DNA-directed RNA interference (RNAi) based treatments, which it develops to address severe and enduring human conditions. Its pipeline features BB-301, an adeno-associated virus…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

56.9×−1.32%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

22.9×−0.59%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

118.7×−0.94%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

30.3×+1.37%